Lipid-accumulated reactive astrocytes promote disease progression in epilepsy

Nat Neurosci. 2023 Apr;26(4):542-554. doi: 10.1038/s41593-023-01288-6. Epub 2023 Mar 20.

Abstract

Reactive astrocytes play an important role in neurological diseases, but their molecular and functional phenotypes in epilepsy are unclear. Here, we show that in patients with temporal lobe epilepsy (TLE) and mouse models of epilepsy, excessive lipid accumulation in astrocytes leads to the formation of lipid-accumulated reactive astrocytes (LARAs), a new reactive astrocyte subtype characterized by elevated APOE expression. Genetic knockout of APOE inhibited LARA formation and seizure activities in epileptic mice. Single-nucleus RNA sequencing in TLE patients confirmed the existence of a LARA subpopulation with a distinct molecular signature. Functional studies in epilepsy mouse models and human brain slices showed that LARAs promote neuronal hyperactivity and disease progression. Targeting LARAs by intervention with lipid transport and metabolism could thus provide new therapeutic options for drug-resistant TLE.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apolipoproteins E / metabolism
  • Astrocytes / metabolism
  • Disease Models, Animal
  • Disease Progression
  • Epilepsy*
  • Epilepsy, Temporal Lobe*
  • Hippocampus / metabolism
  • Humans
  • Lipids
  • Mice

Substances

  • Lipids
  • Apolipoproteins E